FAK signaling
Submission Deadline: 31 Dec 2020
Guest Editor
Volunteer Clinical Associate Professor, Department of Medicine, University of Oklahoma, Oklahoma, OK, USA,Research and Business Development, Promab Biotechnologies, 2600 Hilltop Drive, Richmond, CA, USA
Interests: immunotherapy; CAR-T cells; tumor microenvironment; checkpoint protein; hypoxia; tumor survival signaling
Special Issues in IMR Press journals
Special Issue in FAK signaling
Special Issue in CAR-T Cell Therapy - Novel Approaches and Challenges
Keyword
- Cancer
Published Papers (2)
PLAP -CAR Tcells mediate high specific cytotoxicity against colon cancer cells
Front. Biosci. (Landmark Ed) 2020, 25(9), 1765–1786; https://doi.org/10.2741/4877
(This article belongs to the Special Issue FAK signaling)
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells
in vitro and
in vivo
Front. Biosci. (Landmark Ed) 2020, 25(2), 270–282; https://doi.org/10.2741/4806
(This article belongs to the Special Issue FAK signaling)